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ABSTRACT 
Bioglasses in the system 24.5Na2O.24.5CaO.6P2O5.xCrF2.(45-x)SiO2 have been studied in the composition 
region of x= 0-10 mol%. CrF2. Glass of molar ratio (Ca+Na)/SiO2 ~1.1 is the base material for the glasses containing 
different CrF2 concentrations. X-ray diffraction (XRD), differential scanning calorimetriy (DSC), scanning electron 
microscopy (SEM), energy dispersive spectroscopy (EDS) and Vicher hardness (Hv) measurements have been carried 
out. Crystalline feature of the glasses is followed up by XRD spectroscopy. It is found that crystallinity was enhanced via 
CrF2 addition. More enhancement was confirmed via thermal heat treatment process.  Increasing CrF2 and sintering 
temperature will induce new ordered phases which will be distributed in the main glassy phase. Well formed flouroapatite 
(Ca5(PO4)3F and wollastonite Ca3Cr2(SiO4)3 phases containing fluorine and chromium ions are evidenced in CrF2 
containing glasses. Increasing glass transition temperature Tg and hardness number Hv upon increasing CrF2 
concentration was discussed on bases of formation of additional bonds by the effect of CrF2 molecules. The measured 
temperature window between Tc and Tg was found to have a great influence in material structure. Wide window is a 
feature of amorphous glass which free from CrF2.  The window scale is found to quickly decrease with increasing CrF2, 
since crystalline phases are already formed in glasses containing CrF2.  Formation of crystalline intermediate phases with 
more shielded silicate and phosphate structural is considered as the main reason for increasing Tg and (Hv) of the glasses.  
EDS as well as XRD analyzed spectra confirm that crystalline wollastonite of calcium inosilicate mineral (CaSiO3) phase is 
well formed. The wollastonite species is evidenced to contain small amounts of chromium and fluorine ions which are 
substituting for calcium cations. Wollastonite phases with Cr/Si=1 is the most dominant type. This ratio is a characteristic 
feature of crystalline CaSiO3 species. Small concentration from fluorine ions are involved in apatite phases. Presence of 
both crystalline apatite and wollastonite in the sample matrix promotes its biocompatibility, particularly orthopedic 
bioactivity. As a consequence, some of investigated glasses are recommended to be applicable in dental field of 
applications. This depends on its own crystallinity, hardness, its apatite and wollastonite concentration as biocompatible 
phases in the crystallized glass. 
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Introduction 
Some specific types of oxide glasses and glass ceramics can provide an appropriate biological response and 
result in the formation of a bond with the living tissues[1-5]. New modified dental materials are a derivative from bioactive 
glass ceramics which have different structures and properties when they compared with conventional glasses. Calcium 
phosphosilicate based material is well-known type which has bioactive and bio dental features are concerned in making 
bonds with natural tissues [4-7]. As a result, bioactive materials are known to have a wide range of medical and dental 
applications. They are currently used as a scaffold, bone graft, and coating materials for dental implants.  Some of 
bioactive glasses are able to form HAP in few hours and can simply bind to tissues [6,7]  
Safety of bioactive glasses was the main concern; therefore, different studies were performed to ensure that 
bioactive glasses are safe enough for clinical applications. Welson et al (1981) [8] have reviewed these studies and 
proposed that bioactive glasses are safe for clinical uses. 
Most of previous studies [3-7] are based on SiO2 containing glasses as stronger glass former. The importance of 
silicate glasses was appeared in stimulating gene activation and promote bone regeneration [9]. Phosphate is also 
considered to have an important consideration in view point of bioactivity.  But in some cases, it was proved that P2O5 free 
glasses could also offer bioactivity [9,10]. Calcium   ions play an important role in bone regeneration in terms of bone 
metabolism [8-10].  Some of calcium ions in Bioglass® are considered to be readily substituted with strontium or chromium 
ion which have been proven to uptake cellular activities and are effective for bone regeneration [10].  
Recently, the bioactive glasses are modified to contain  fluoride ions, since it prevents demineralization and 
enhances reminerization processes [10]. In addition, it has good activity in prevention secandary caries. The role of 
fluorine ion is appeared in forming fluoroapatite phases which played the most effective influences on solubility of enamel 
[10]. Recent studies have been performed  to shed more light on  the role of F
-
 ions in properties and structure of biodental 
glasses. It was reported that glasses containing CaF2 is more biocompatable [5] and more safly to applied. 
In the present work, the investigated glasses contain CaO and CrF2 in the composition with an aim that CrF2 can 
effectively enhance the structure and bioactivity of the investigated material. Understanding the structures of glasses and 
crystallized glasses is important for further applications such as plasma spray coating onto implant materials. In this work, 
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chromium fluoride -substituted bioactive glasses and their crystallized structure were analyzed using XRD, DSC, EDS and 
SEM techniques.  
2.  Experimental details  
2.1. Sample preparation  
Glass samples were prepared by using chemically pure SiO2, CaCO3, Na2CO3, and CrF2.Using nominal composition 
24.5Na2O, 24.5CaO, 6 P2O5- xCrF2and(45-xSiO2) mol% (where x =0, -10 mole %), The batches were accurately 
weighed out and then melted in alumina crucibles using an electric furnace at temperature 1200-1400°C .Tthe melts were 
shacked well several times to achieve homogeneity. Each melt was stirred by rotating the crucible several times every 20 
mins. The homogeneous melts were cast after an  hour of melting into preheated stainless steel molds. 
 2.2 Measurement techniques  
2.2.1. X-ray diffraction (XRD)  
The amorphous or crystalline nature of the structure was observed by X- ray diffraction. XRD measurements 
were carried out on powdered samples at (Metallurgical Institute, El-Tebbeen- Helwan) using a Bruker D8 Advance 
powder XRD system with a (Cu k)  radiation. The range of diffraction is changed from 10° to 70° using a dwell time of 0.4 
seconds 
2.2.2 Scanning electron microscope (SEM)  
The morphology of the sample has been observed via (Scanning Electron Microscope unit, Mansura University) using a 
JEOL-JSM-6510 LV Model with a working accelerating voltage of 25 kV and an increasing size image up to 300.000X. 
The surface of the samples has been covered with a thin layer of gold before SEM measurement to withstand the 
environment inside the microscope.  
2.2.3. Energy dispersive X-ray analysis (EDS)  
The energy dispersive X-ray spectra (EDX) of the samples were also acquired during their scanning electron 
microscopic (SEM) measurement. The EDX spectrum normally involves peaks corresponding to X-rays generated by 
emission from different energy-levels in different elements. The higher concentrated elements in the sample present the 
most intense peaks in the spectrum. This technique is widely used for the identification of the elemental composition 
present in the sample. 
2.2.4. Heat treatment (HT)  
The selected samples containing 3 and 10 mol% CrF2, were heated in a muffle furnace (Heraeus KR170) 
controlled within ± 2 °C. The samples were heat-treated at temperatures 500 
o
C and 600 
o
C for treatment time interval of  
4 hours . After heating, the glasses were then kept into the furnace and held at the temperature of heat treatment for the 
desired time before cooling normally at room temperature. 
2. 2.5 Differential Scanning Calorimetry 
 DSC analysis was carried out using a NETZSCH STA 409C/CD instrument. Known mass (≈30 mg) of crushed 
samples was placed into an aluminum pan then sealed with a crimped lid and heated from 25°C to 1000°C at a rate of 
5°C/min with argon as carrier gas at a flow rate of 30 cm3 /min. 
3 Results and Discussion 
3.1 XRD Spectroscopy 
Metal fluoride such  (CrF2) gives the glasses good advantages toward improvements of their biological properties 
like extremely high resistant to thermal shock, high mechanical strength, good chemical stability, crystallinity and 
bioactivity [11-13]. The advantage of the present glasses is that it can easily be crystallized by adding of even little 
concentration from CrF2 to the host matrix.  Extra structural and properties enhancement is considered through applying 
thermal heat treatment route as an effective controlling technique. In such situation, the glass can simply be transformed 
to glass ceramic with further controlled crystallization behavior.   
It can be shown from figure 1 that, a small addition of CrF2 to glasses has a profound effect on crystallization 
process which is achieved even at the reduced dopant level of CrF2 (0.2 mol%). At lower concentration, for example (0 
Crf2) there is no any tendency toward crystallization.  XRD pattern of chromium fluoride free glass (0 CrF2) showed a 
broad hump which reflects the amorphous nature of the base glass. Amorphous orthophosphate (Na3PO4) and both 
calcium and sodium silicate mixed phases (CaSiO3 and Na2SiO3) are the most dominant forming species [4,14] in base 
glass. On the other hand, few addition of CrF2 (0.2 and 0.5 mol%)  is found to have strong influence, since some XRD 
peaks superimposed on the wide diffracted hump are clearly appeared. The broad diffraction was eventually disappeared 
and more sharper peaks centered at about 22, 31, 34 and 47° were simply observed upon more CrF2 addition. Different 
crystalline phases can be evidenced from   the successfully increment in both sharpness and number of the diffraction 
peaks upon increasing CrF2 contents. We suggest that, the base glass has already contained a high enough concentration 
of nuclei which are ready to aggregate to form crystalline phases by the help of dopant additive and /or sintering process.  
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Therefore, initial CrF2 addition even with lower concentration (0.2 mol%) pushes the matrix toward crystallization. These 
changes lead one to suggest that CrF2 can act as an enhancer for crystallization. This feature can be extracted from XRD 
patterns representing the studied glasses, since sharper peaks are evidenced upon increasing CrF2 concentration, figure 
1. These diffraction patterns are indexed to crystalline wollastonite Ca3Cr2(SiO4)3 [card no. 82-1914], and fouroaptite 
crystalline (Ca5(PO5)3F  [card no. 2-845]. In specific manner, both chromium silicate (Cr3(Si3O9) and the main crystalline 
phase from pseudowollastonite (Ca3(Si3O9) [4,14,15] are also evidenced to be constructed.  
In terms of biocompatibility assessment, it could suggest that both the bioactivity and compatibility are attained, 
since both apatite and wollstonite crystals are documented to be present in the main glass matrix under the effect of CrF2 
addition.  However, the highest extreme of crystallinity has not yet reached via CrF2 addition.  Alternatively, more 
enhanced phases can be obtained via sintering the glass at the onset of crystallization temperatures which is determined 
from DSC curves of the investigated glasses. 
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Figure 1 XRD patterns for glass containing 0, 0.2, 0.5, 3 and 10 mol% CrF2 
3.2 DSC and Hv results  
DSC curves for glasses containing 0, 3 and 10 mol% CrF2 are presented by figure 2(a-c). Both glass transition 
temperature (Tg) and peak crystallization temperature (Tc) are the two main features appeared in DSC curves. It can be 
realized that window between Tg and Tc is differed from one glass to another. This range is a guide for how the heat 
treating or sintering temperature can be rightly chosen to produce crystallized phases in glasses.  For example, a wide 
processing range between the two parameters (Tg and Tc) gives an evidence that sinter process has little effect on 
crystallization. On the other hand, if the window between Tg and Tc is small, the material can undergo additional 
crystallization under effect of sintering temperature.  
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Figure 2 DSC curves for glasses containing 0 (curve a), 3 (curve b) and 10 (curve c) mol% CrF2 
The determined values of Tg was found to increase with increasing CrF2 (figure 3). Increasing Tg with increasing 
CrF2 concentration leads to increasing bond capacity. As a consequence the hardness number of the glass is shown also 
to increase with increasing CrF2 concentration (see figure 4). Increasing both Tg and Hv  with increasing CrF2 is in 
harmony with decreasing  window between Tc and Tg upon CrF2 addition as is seen from figures 2(a-c).  Relatively wider 
range between both Tg (400 °C) and onset of crystallization temperature (600 °C) for CrF2 free glass is noticed. This wider 
range is referred to amorphous nature of the glass as confirmed from XRD pattern, figure 1. On the other hand, the 
window between Tc and Tg is continuously decreased with increasing CrF2 concentration, figure 2(b-c), which reflect the 
crystalline nature of the glasses. 
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Figure 3 Change of Tg with CrF2 concentration 
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Figure 4 relationship between Hv and CrF2 content 
 The above discussion leads one to consider that, sintering process will has more influences on glasses of high 
CrF2 (10 mol%), since its Tc-Tg window is the smallest when it compared with that of glass containing 0 and 3 mol%.  
However, the selected glasses are all thermally sintered at the onset of glass transition Tg and also at the onset of 
crystallization temperature (600 °C). XRD measurements were carried out on some of the sintered glasses. The obtained 
results are compared with XRD patterns of as prepared glasses. 
  Figure and 5 and 6 presented XRD of sintered glasses containing 3 and 10 mol% respectively. The glasses are 
thermally treated at 500 and 600 °C for 4 hours. It can be seen from these figures that the crystallinity is enhanced, 
particularly in glasses containing 10 mol% CrF2. New additional XRD peaks are appeared at 26, 29 and 51° which leads to 
inducing new additional crystalline phases under the effect of sintering process. The well resolved sharper XRD pattern at 
34 and 47° are indexed to crystalline wollastonite Ca3Cr2(SiO4)3 [card no. 82-1914], and fluoroaptite crystalline 
(Ca5(PO5)3F  [card no. 2-845]. For simplicity a comparison between XRD patterns for sintered glasses (at 600 °C) 
containing 3 and 10 mol% CrF2 is presented in figure 7. A clear difference can be observed, since new peaks are only 
developed in glass of 10 mol% CrF2.  
Glasses composed from the above given crystalline phases can play a main role in some of medical applications. 
They can be recommended to be used as useful inorganic counterpart of the glass ionomer cement (GIC) which is used 
as a dental restorative material [4,16-18]. The higher Tg, Hv and crystallinity of glass containing 10 mol% CrF2 is highly 
recommended it for such biodental application. 
 
Figure  5 XRD patterns for glass containing 3 mol% CrF2 (a), treated  
at 500 °C (b) and sintered at 600 °C (c) for 4 hrs. 
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Figure  6 XRD patterns for glass containing 10 mol% CrF2 (a), treated  
at 500 °C (b) and sintered at 600 °C (c) for 4 hrs. 
 
 
Figure 7 XRD patterns for glass containing 3 mol% and 10 mol% CrF2  
both treated at 600 °C for 4 hrs. 
 
3.3 SEM and EDS spectroscopy 
The morphological structure of the two glasses of 0 mol% CrF2 and 10 mol% CrF2 was analyzed using SEM 
micrographs under the same magnifications (see figure 8 (a,b)). As can be seen from the morphologies of particles, there 
is a limited distribution of small particles in sample of 0 mol% CrF2. On the other hand, large agglomerates are evidenced 
in micrograph of sample containing 10 mol%. These agglomerates consist of fine particles that could be welded together. 
The microstructure was observed to be almost like a needle and/or rod
 
like shapes which characterize the crystalline 
wollastonite and apatite [1,4,15-20]. SEM images showed that the distributed nanoparticles were dense and highly 
concentrated evenly in glass which contain 10 mol% CrF2. In addition to this, although these smaller crystallites are so 
closely arranged together, a clear boundary between neighboring crystallites can still be observed, Fig. 8 (b)).  
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Figure 8  SEM of sample containing 0 mol% CrF2 (a) and 10 mol% CrF2( b)  
 
 
Figure 9  EDS spectra of glass containing 10 mol% CrF2. 
The elemental composition has been investigated by the energy dispersion X-ray spectroscopy (EDS) analysis. 
Figure 9 shows EDS patterns of glass containing 10 mol% CrF2. From the EDS spectrum, the presence of Na, Ca, Si, Cr 
and O has been confirmed and the calculated percentages reveal almost the same ratio of CrO2/SiO2 CaO/ SiO2 as in 
crystalline wollastonite phases. EDS analysis ascertained that the crystallites of 10 mol% CrF2 are composed of crystalline 
cromium silcate wollastonite phases, since the rato of Cr/Si is found to be around unity which means that most of the 
phase constituent are found in its ordered state.  
4 Conclusion 
Bioglasses and glass ceramics  containing different CrF2 concentrations have been studied by different structural 
techniques. Amorphous nature of the glass free from CrF2 is confirmed by XRD. Some types of crystalline species are 
formed in CrF2 containing glasses. Well formed flouroapatite (Ca5(PO4)3F and wollastonite Ca3Cr2(SiO4)3 phases 
containing fluorine and chromium ions are evidenced in CrF2 containing glasses. More enhancement in crystallinity was 
confirmed via thermal heat treatment process. Wollastonite phases with Cr/Si=1 is the most dominant crystalline phase.  
Increasing glass transition temperature Tg and hardness number Hv upon increasing CrF2 concentration was discussed on 
bases of formation of additional bonds by the effect of CrF2 molecules. Presence of both crystalline apatite and 
wollastonite in the sample matrix promotes its biocompatibility, particularly orthopedic bioactivity. 
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